Anti-VEGF therapies aim to inhibit the VEGF pathway, thereby reducing the blood supply to tumors. This can effectively starve the tumor of the nutrients and oxygen it needs to grow. These therapies can be classified into several categories, including monoclonal antibodies, small molecule inhibitors, and VEGF-trap therapies.
